Ignite Creation Date:
2024-05-06 @ 5:37 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05378425
Status:
RECRUITING
Last Update Posted:
2024-01-29
First Post:
2022-05-12
Brief Title:
A Study of NTX-1088 a Monoclonal Antibody Targeting the Poliovirus Receptor PVR CD155 as Monotherapy and Combined With Pembrolizumab
Sponsor:
Nectin Therapeutics Ltd
Organization:
Nectin Therapeutics Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-12
First Submit QC Date:
May 12 2022
Study First Post Date:
2022-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-25
Last Update Post Date:
2024-01-29
Last Update Post Date Type:
ACTUAL